Updated Jul 16, 2026
Duke John D is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $25K.

John D. Duke is the Chief Executive Officer and Director of Harvard Bioscience Inc, a company focused on developing technologies and products for life sciences research. He has been involved in the company's strategic direction and operations, contributing to its growth in the scientific instruments market.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-23 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 75.0K | $0.00 | |
| 2026-03-17 | HBIO | HARVARD BIOSCIENCE INC | P — Open-market purchase | 5.0K | $5.01 | $25K |
| 2025-08-08 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 500.0K | $0.00 | |
| 2025-08-08 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 500.0K | $0.00 |
John D. Duke is the Chief Executive Officer and Director of Harvard Bioscience Inc, a company focused on developing technologies and products for life sciences research. He has been involved in the company's strategic direction and operations, contributing to its growth in the scientific instruments market.…
Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Duke John D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.